Search the Appendices of Resolution CM/Res(2018)1
1932 found
INN | ATC Code ▼ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
AZATHIOPRINE | L04AX01 | SI | POM | VALID | ||||
TERIFLUNOMIDE | L04AK02 | SI | POM | VALID | ||||
LEFLUNOMIDE | L04AK01 | SI | POM | 14-05-2018 | 5363-I-42/03 | 31-01-2003 | VALID | |
VILOBELIMAB | L04AJ10 | SI | POM | 05-05-2025 | EMEA/H/C/006123 | 13-01-2025 | VALID | |
IPTACOPAN | L04AJ08 | SI | POM | 22-10-2024 | EMEA/H/C/005764 | 17-05-2024 | VALID | |
CROVALIMAB | L04AJ07 | SI | POM | 22-10-2024 | EMEA/H/C/006061 | 22-08-2024 | VALID | |
ZILUCOPLAN | L04AJ06 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005450 | 01-12-2023 | VALID | |
SUTIMLIMAB | L04AJ04 | SI | POM | 18-08-2023 | EMEA/H/C/005776 | 15-11-2022 | VALID | |
RAVULIZUMAB | L04AJ02 | SI | POM | 05-05-2025 | VALID | |||
ROZANOLIXIZUMAB | L04AG16 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005824 | 05-01-2024 | VALID | |
UBLITUXIMAB | L04AG14 | SI | POM | 14-11-2023 | EMEA/H/C/005914 | 31-05-2023 | VALID | |
OFATUMUMAB | L04AG12 | SI | POM | VALID | ||||
OCRELIZUMAB | L04AG08 | SI | POM | VALID | ||||
ALEMTUZUMAB | L04AG06 | SI | POM | 06-05-2025 | VALID | |||
RITLECITINIB | L04AF08 | SI | POM | 14-11-2023 | EMEA/H/C/006025 | 15-09-2023 | VALID | |
DEUCRAVACITINIB | L04AF07 | SI | POM | 18-08-2023 | EMEA/H/C/005755 | 24-03-2023 | VALID | |
UPADACITINIB | L04AF03 | SI | POM | VALID | ||||
BARICITINIB | L04AF02 | SI | POM | VALID | ||||
TOFACITINIB | L04AF01 | SI | POM | VALID | ||||
ETRASIMOD | L04AE05 | SI | POM | 13-05-2024 | EMEA/H/C/006007 | 16-02-2024 | VALID | |
SIPONIMOD | L04AE03 | SI | POM | VALID | ||||
FINGOLIMOD | L04AE01 | SI | POM | VALID | ||||
TACROLIMUS | L04AD02 | SI | POM | 13-11-2018 | VALID | |||
CICLOSPORIN | L04AD01 | SI | POM | VALID | ||||
MIRIKIZUMAB | L04AC24 | SI | POM | 14-11-2023 | EMEA/H/C/005122 | 26-05-2023 | VALID | |
SPESOLIMAB | L04AC22 | SI | POM | 18-08-2023 | EMEA/H/C/005874 | 09-12-2022 | VALID | |
RISANKIZUMAB | L04AC18 | SI | POM | VALID | ||||
DACLIZUMAB | L04AC01 | SI | Not authorised | VALID | ||||
GOLIMUMAB | L04AB06 | SI | POM | VALID | ||||
CERTOLIZUMAB PEGOL | L04AB05 | SI | POM | VALID | ||||
ADALIMUMAB | L04AB04 | SI | POM | VALID | ||||
INFLIXIMAB | L04AB02 | SI | POM | VALID | ||||
ETANERCEPT | L04AB01 | SI | POM | 13-04-2017 | 5363-I-539/03 | 11-08-2003 | VALID | |
CLADRIBINE | L04AA40 | SI | POM | 21-02-2020 | VALID | |||
APREMILAST | L04AA32 | SI | POM | 05-05-2025 | None | VALID | ||
ABATACEPT | L04AA24 | SI | POM | VALID | ||||
ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) | L04AA04 | SI | POM | VALID | ||||
PLERIXAFOR | L03AX16 | SI | POM | 14-11-2023 | None | VALID | ||
GLATIRAMER ACETATE | L03AX13 | SI | POM | VALID | ||||
LENTINAN | L03AX01 | SI | Not authorised | VALID | ||||
ALDESLEUKIN | L03AC01 | SI | Not authorised | VALID | ||||
ROPEGINTERFERON ALFA-2B | L03AB15 | SI | POM | VALID | ||||
INTERFERON BETA-1B | L03AB08 | SI | I | 5363-I-656/03 | 14-10-2003 | VALID | ||
INTERFERON BETA-1A | L03AB07 | SI | I | 5363-I-829/03 | 23-12-2003 | VALID | ||
LIPEGFILGRASTIM | L03AA14 | SI | POM | VALID | ||||
PEGFILGRASTIM | L03AA13 | SI | POM | 06-05-2025 | VALID | |||
FILGRASTIM | L03AA02 | SI | POM | VALID | ||||
ABIRATERONE | L02BX03 | SI | POM | VALID | ||||
ABARELIX | L02BX01 | SI | Not authorised | VALID | ||||
EXEMESTANE | L02BG06 | SI | I | 512/B-443/01 | 10-12-2001 | VALID |